Removing toxicity

Liver toxicity or unmanageable pharmacokinetics have killed a lot of drugs over the years. But with this week's announcement of Phase I safety data for a nucleotide reverse transcriptase inhibitor that had been shelved due to toxicity, Heidelberg Pharma AG believes it now has sound evidence to prove that its Enhanced Pro-Drug Technology (EPD) platform can salvage

Read the full 576 word article

User Sign In